FDA Investigator Daniel J Brown

Daniel J Brown has conducted inspections on 11 sites in 1 countries as of 20 Dec 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
11
Last Inspection Date:
20 Dec 2010
Investigator Role:
FDA Investigator
Redica ID:
100006977
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Daniel J Brown:
Adam J Wilson, Aditi S Thakur, Alan M Barker, Alanna L Mussawwir Bias, Alexandra A Carrico, Amanda M Dunneback, Amanda S Zorn, Amy S Graf, Andrea F White, Andrew J Barrowcliff, Anita Narula, PhD, Ann Raju Daniel, Anthony F Lorenzo, Anthony R Petriella, Antonio M Hampton, Arsen Karapetyan, Art O Czabaniuk, Aurora Miha Trifanov, Azza Talaat, Bei Y He, Brandi N Mcgrady, Brent M Dehaan, Brentley S Collins, Brian D Nicholson, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Carmen M Faraianu, Caroline H Le, Caroline Strasinger, Carrie Ann Plucinski, Catherine V Quinlan, Charles I Ann, Charles L Zhou, Cheryl M Monroe, Christian D Lynch (CDL), Christopher D Leach, Constantin Y Philopoulos, Courtney E Hillier, Danial S Hutchison, Daniel B Arrecis, Daniel J Gorski, Darren S Morgan, David A Paterson, David J Gasparovich, David Perkins, Dawn C Olenjack, Deborah M Trout, Debra I Love, Dennis E Swartz, Douglas C Kovacs, Edwardstine J Reese, Eliezar Ramos, Elizabeth M Kelley, Elizabeth P Mayer, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Erin M Miller, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Hassan Ali, Helen B Ricalde, Ifueko Osemwota, Jacob G Lutz, Jacqueline Mdiaz Albertini, James K Ireland, James R Evans, James W Plucinski, Janet L Bowen, Jason F Chancey, Jeffrey A Sommers, Jeffrey D Meng, Jennifer R Johnson, Joie A Navarrete, Joohi Castelvetere, Joseph A Piechocki, Joseph R Strelnik, Joseph T Madak, Justin A Boyd, Kathryn E Ogger, Kelley L Clark, Kristina Nastovski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Burke, Lauren E Sexton, Lauren M Lilly, PhD, Lequita M Mayhew, Leslie A Paul, Linda F Murphy, Lindsey Brown, PhD, Lindsey M Schwierjohann, Lisa C Lewis, Mark G Peterson, Martha Sullivan Myrick, Matt D Suedkamp, Matthew B Casale, Matthew J Gretkierewicz, Meisha Waters, Miah I Schneider, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele Perry Williams, Mihaly S Ligmond, Misty D Harvey, Mobin A Tawakkul, Myra K Casey, Nelson A Rodriguez, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Omotunde O Osunsanmi, Patsy J Domingo, Paula A Trost, Philip A Klimkewicz, Phung Thien Nguyen, Prabhu P Raju, Ralph A Erickson, Raymond R Roy, PhD, Rebecca E Dombrowski, Regina T Brown, Renee L Rice, PhD, Robert C Coleman, Robert D Tollefsen, Robert M Barbosa, Robert R Barbosa, Roger A Hartman, Ronald G Crawford, Rose Ashley, Russell K Riley, Salwa K Poole, Sandra A Boyd, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Rhoades, Scott A Golladay, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Sneha S Patel, Soyinka S Eneng, Susan M Jackson, Susan P Bruederle, Theodore N Sietsema, Thomas A Peter, Thomas J Cosgrove, Tina M Pawlowski, Tina S Roecklein, Todd M Stankewicz, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Tracey L Taylor, Vera M Anderson, William D Tingley, Yvonne E Lozano

Daniel J Brown's Documents

Publish Date Document Type Title
May, 2009 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2009-06-19
June, 2002 FDA 483 Response DSC Laboratories, LLC - Form 483R, 2002-06-21
June, 2002 FDA 483 DSC Laboratories, LLC - Form 483, 2002-06-11
June, 2002 EIR DSC Laboratories, LLC - EIR, 2002-06-11
December, 2010 FDA 483 Ash Stevens LLC - Form 483, 2010-12-22
May, 2000 EIR Pharmacia & Upjohn Company LLC - EIR, 2000-05-12
December, 2004 EIR ENDO USA, Inc. - EIR, 2004-12-06
May, 2009 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2009-05-12
December, 2004 FDA 483 ENDO USA, Inc. - Form 483, 2004-12-06
February, 2002 FDA 483 Response Mead Johnson & Company, LLC - Form 483R, 2002-02-27
February, 2002 FDA 483 Mead Johnson & Company, LLC - Form 483, 2002-02-13
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
February, 2002 EIR Mead Johnson & Company, LLC - EIR, 2002-02-13
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
September, 2008 FDA 483 Martin Ekwealor Pharmaceuticals, Inc. - Form 483, 2008-09-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more